PACT MANUFACTURING SPECIALIST EARNS CPGP CERTIFICATION
Olga Ganz, one of PACT’s two cell manufacturing specialists, has recently completed the necessary qualifications for the American Society for Quality, Certified Pharmaceutical GMP Professional (CPGP). A CPGP understands the good manufacturing practices (GMP) as …
November 9, 2021KIM MCDOWELL PROMOTED TO DIRECTOR OF REGULATORY AFFAIRS FOR PROGRAM FOR ADVANCED CELL THERAPY
Kimberly McDowell, MD, PhD, has been named Director of Regulatory Affairs for the UW Program for Advanced Cell Therapy (PACT). McDowell has served as the program’s associate director of regulatory affairs since 2019, and has …
August 4, 2021UW BEGINS NEW CLINICAL TRIAL TO TREAT FATAL BLOOD DISEASES IN CHILDREN, YOUNG ADULTS
The trial is being sponsored by the UW Program for Advanced Cell Therapy (PACT) in partnership with the Department of Pediatrics, Division of Pediatric Hematology, Oncology and Bone Marrow Transplant. The Food and Drug Administration-approved …
June 2, 2021Galipeau Chats with UWCCC Emerging Leadership Board
In December 2020, PACT Director Jacques Galipeau took part in Emerging Leadership Board at UW Carbone Cancer Center’s Five Minutes at Five Q&A session about his work in the PACT Program. To view the interview, …
April 14, 2021UW Carbone Cancer Center Receives FDA Clearance to Test New Regenerative Medicine Therapy for Radiotherapy-Induced Dry Mouth
The University of Wisconsin Carbone Cancer Center has the go-ahead to start clinical trials on a first-in-human cell therapy to treat a common side effect of radiation therapy. This investigational new drug license, or IND, recently …
September 8, 2020- More News
Integrated personalized cell technologies for improving health outcomes in children and adults